reference/14835265

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14835265

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	232
issn	1387-2877 1875-8908
issueIdentifier	1
pageRange	223-232
publicationName	Journal of Alzheimer's disease : JAD
startingPage	223
bibliographicCitation	Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ. A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease. J Alzheimers Dis. 2016 Jul 22;54(1):223–32. doi: 10.3233/jad-160544. PMID: 27447428.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4803-6323 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9ca22de2517f4464ed02bbae4c8aa5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4624-7071 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fe66223da70b55dfaa5294cac10b3e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b6a4b6859a2fe9b61dd0879784c032c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7138560142515e44555e9cab6a2429ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89a54c77e9e1ca4450d13379a998ea36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f9a74dd721113a9525a4e12bd54b6f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39accff6d7f1b41bd0606010e2eac3d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134fe8a1139d4c369cc9dc912cf4c451 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4189396a42f1b35ec8ac14f31fd95894 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2853518e4afade85feed11d671ec332f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1182-0907 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_333f8d5b31be4ff86b8b0039f991adce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f1ff8fce6943d8d2bf40c2ea929ecb5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c0f3044041d5fadba675392afd9d163 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac5ede92e3207721bf7c722b10a4bc1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5b72f5e50d3874beea571a285c021a2
date	2016-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3233/jad-160544 https://pubmed.ncbi.nlm.nih.gov/27447428
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1875-8908 https://portal.issn.org/resource/ISSN/1387-2877
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer’s Disease
discusses	http://id.nlm.nih.gov/mesh/M0016224 http://id.nlm.nih.gov/mesh/M0469770 http://id.nlm.nih.gov/mesh/M0025678 http://id.nlm.nih.gov/mesh/M0024786 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0202730 http://id.nlm.nih.gov/mesh/M0156860 http://id.nlm.nih.gov/mesh/M0028008
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064586Q000627 http://id.nlm.nih.gov/mesh/D018696Q000627 http://id.nlm.nih.gov/mesh/D000544Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D064586Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016875Q000134 http://id.nlm.nih.gov/mesh/D018696Q000009 http://id.nlm.nih.gov/mesh/D015415Q000134 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000544Q000134 http://id.nlm.nih.gov/mesh/D010446Q000134 http://id.nlm.nih.gov/mesh/D000544Q000000981 http://id.nlm.nih.gov/mesh/D049268 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D038524 http://id.nlm.nih.gov/mesh/D003071Q000187 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016229Q000134 http://id.nlm.nih.gov/mesh/D005500
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25960

Total number of triples: 70.